Market Overview:

The global extracorporeal membrane oxygenation machine market is expected to exhibit a CAGR of 5.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Extracorporeal membrane oxygenation (ECMO) machine refers to a miniaturized heart-lung equipment used for supporting respiratory and cardiac functions during transplant surgeries. ECMO drains the blood and removes carbon dioxide from the patient’s body to artificially oxygenate the red blood cells. It is also used in late-stage treatments or post-cardiopulmonary bypass with heart or lung failure. ECMO is commonly available in two variants, namely, Veno-Venous (VV) and Veno-Arterial (VA). VV involves attaching cannulas to large veins in the body to drain the blood and remove the carbon dioxide, thereby providing support only to the lungs. Whereas, VA ECMO is used for supporting the functioning of both heart and lungs by draining and pumping the blood throughout the body.

The increasing prevalence of respiratory and cardiovascular disorders across the globe is one of the key factors driving the growth of the market. ECMO is used for both adults, newborns and children suffering from respiratory or cardiac failure due to congenital disabilities, trauma or severe infections. Furthermore, the rising geriatric population, which is more susceptible to chronic medical ailments, is providing a thrust to the market growth. In line with this, increasing patient awareness regarding the benefits of timely ECMO procedures is also contributing to the growth of the market. Various technological advancements, such as the development of polymethyl pentene (PMP) fiber-based artificial membranes with low-resistance and improved biocompatibility, are acting as other growth-inducing factors. Equipment manufacturers are also developing compact ECMO machines for enhanced portability and convenient oxygenation of the blood. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global extracorporeal membrane oxygenation machine market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, modality, patient type and application.

Breakup by Component:

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories
   

Breakup by Modality:

• Veno-Arterial
• Veno-Venous
• Arterio-Venous
   

Breakup by Patient Type:

• Neonates
• Pediatric
• Adult
   

Breakup by Application:

• Respiratory
• Cardiac
• ECPR
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, ALung Technologies Inc., Braile Biomedical, Eurosets, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Nipro Medical Corporation, Origen Biomedical, Inc., Terumo Corporation and Xenios AG.

Report Coverage:

Key Questions Answered in This Report:

• How has the global extracorporeal membrane oxygenation machine market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global extracorporeal membrane oxygenation machine market?
• What are the key regional markets?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the modality?
• What is the breakup of the market based on the patient type?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global extracorporeal membrane oxygenation machine market and who are the key players?
• What is the degree of competition in the industry?